Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CryoCor has filed a formal complaint with the US International Trade Commission or ITC alleging that CryoCath Technologies has engaged in unfair trade practices by infringing on several CryoCor patents with its cryoablation system.
Subscribe to our email newsletter
CryoCor is requesting that the ITC initiate an investigation and issue an exclusion order to bar the importation into the US of infringing CryoCath cryoablation products. CryoCor’s complaint covers three patents exclusively licensed to CryoCor in certain fields of use related to its Cardiac Cryoablation System, including patents covering pre-cooling technologies that CryoCor considers important to CryoCath’s cryoablation system.
Ed Brennan, president and CEO of CryoCor, said: “Our request for this investigation further reinforces our strategy to protect our intellectual property rights. Importantly, an ITC investigation has a fast timeline for completion, usually just over one year. If we prevail, the ITC may issue a ban on importation of CryoCath’s cryoablation system into the US. We expect to hear from the ITC within 30 days and will provide an update upon their response.”